Response to A+CHP by CD30 expression in the ECHELON-2 trial. Advani, R. H., Horwitz, S. M., Iyer, S., Bartlett, N. L., Kim, W., Tilly, H., Belada, D., Feldman, T., Illes, A., Jacobsen, E. D., Huettmann, A., Zinzani, P., O'Connor, O. A., Trepicchio, W. L., Miao, H. H., Rao, S., Onsum, M., Manley, T., Illidge, T. AMER SOC CLINICAL ONCOLOGY. 2019

View details for Web of Science ID 000487345806300